Patents Assigned to CAROLUS THERAPEUTICS, INC.
  • Publication number: 20140005096
    Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
    Type: Application
    Filed: July 15, 2013
    Publication date: January 2, 2014
    Applicant: Carolus Therapeutics, Inc.
    Inventors: Joshua Robert SCHULTZ, Benedikt VOLLRATH, Court TURNER
  • Publication number: 20100183598
    Abstract: Disclosed herein, in certain embodiments, is a method for treating a cardiovascular disorder. In some embodiments, the method comprises co-administering an inhibitor of inflammation and an agent used to treat a cardiovascular disorder.
    Type: Application
    Filed: November 12, 2009
    Publication date: July 22, 2010
    Applicant: CAROLUS THERAPEUTICS, INC.
    Inventors: Joshua Robert Schultz, Benedikt Vollrath, Court Turner
  • Publication number: 20100093636
    Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 15, 2010
    Applicant: CAROLUS THERAPEUTICS, INC.
    Inventors: Joshua Robert Schultz, Benedikt Vollrath, Court Turner